33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
View analysts' price targets and recommendations, and compare them with competitors.
$49.00
Analysts expect the stock price to increase by 45.83%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
1.24B
The estimated revenue has increased from the previous period.
-788.81M
The estimated EBITDA has decreased from the previous period.
0.22
The estimated EPS has increased from the previous period.
118.22M
The estimated net income has increased from the previous period.
-887.36M
The estimated EBIT has decreased from the previous period.
1.39B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
4.35B
Revenue has increased from the previous period.
66.85%
Revenue growth rate is unchanged from the previous period.
-2.78B
EBITDA has decreased from the previous period.
-63.74%
EBITDA margin is unchanged from the previous period.
-3.12B
EBIT has decreased from the previous period.
-71.70%
EBIT margin is unchanged from the previous period.
526.90M
Depreciation has increased from the previous period.
3.99B
Total cash has increased from the previous period.
91.68%
Cash percentage is unchanged from the previous period.
876.73M
Receivables have increased from the previous period.
20.14%
Receivables percentage is unchanged from the previous period.
309.65M
Inventories have increased from the previous period.
7.11%
Inventory percentage is unchanged from the previous period.
381.66M
Accounts payable has increased from the previous period.
8.77%
Payables percentage is unchanged from the previous period.
-423.61M
Capital expenditure has increased from the previous period.
-9.73%
CapEx percentage is unchanged from the previous period.
11.55%
WACC is unchanged from the previous period.
11.58%
Cost of equity is unchanged from the previous period.
4.40%
Cost of debt is unchanged from the previous period.
1.52
Beta is unchanged from the previous period.
534.88M
Diluted shares outstanding is unchanged from the previous period.
99.49M
Total debt is unchanged from the previous period.
23.34B
Total equity is unchanged from the previous period.
23.44B
Total capital is unchanged from the previous period.
0.42%
Debt weighting is unchanged from the previous period.
99.58%
Equity weighting is unchanged from the previous period.
-3.12B
EBIAT has decreased from the previous period.
-3.34B
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
-99.35B
Terminal value is unchanged from the previous period.
-71.64B
Enterprise value is unchanged from the previous period.
-36.05M
Net debt is unchanged from the previous period.
-71.60B
Equity value is unchanged from the previous period.
-133.86
Equity value per share is unchanged from the previous period.
